(Press-News.org) Diseases that progressively destroy nerve cells in the brain or spinal cord, such as Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), are devastating conditions with no cures.
Now, a team that includes a University of Iowa researcher has identified a new class of small molecules, called the P7C3 series, which block cell death in animal models of these forms of neurodegenerative disease. The P7C3 series could be a starting point for developing drugs that might help treat patients with these diseases. These findings are reported in two new studies published the week of Oct. 1 in PNAS Early Edition.
"We believe that our strategy for identifying and testing these molecules in animal models of disease gives us a rational way to develop a new class of neuroprotective drugs, for which there is a great, unmet need," says Andrew Pieper, M.D., Ph.D., associate professor of psychiatry at the UI Carver College of Medicine, and senior author of the two studies.
About six years ago, Pieper, then at the University of Texas Southwestern Medical Center, and his colleagues screened thousands of compounds in living mice in search of small, drug-like molecules that could boost production of neurons in a region of the brain called the hippocampus. They found one compound that appeared to be particularly successful and called it P7C3.
"We were interested in the hippocampus because new neurons are born there every day. But, this neurogenesis is dampened by certain diseases and also by normal aging," Pieper explains. "We were looking for small drug-like molecules that might enhance production of new neurons and help maintain proper functioning in the hippocampus."
However, when the researchers looked more closely at P7C3, they found that it worked by protecting the newborn neurons from cell death. That finding prompted them to ask whether P7C3 might also protect existing, mature neurons in other regions of the nervous system from dying as well, as occurs in neurodegenerative disease.
Using mouse and worm models of PD and a mouse model of ALS, the research team has now shown that P7C3 and a related, more active compound, P7C3A20, do in fact potently protect the neurons that normally are destroyed by these diseases. Their studies also showed that protection of the neurons correlates with improvement of some disease symptoms, including maintaining normal movement in PD worms, and coordination and strength in ALS mice.
Of mice and worms
In the ALS mouse model, a highly active variant of the original P7C3 molecule, known as P7C3A20, which the investigators synthesized, largely prevented death of the nerve cells within the spinal cord that are normally destroyed by this disease. The P7C3 molecule also worked, but was not as effective at protecting neurons in this model.
As cell survival increased in the ALS model, coordination and strength of the mice improved as well. Mice that were given P7C3A20 were able to stay on a rotating rod much longer than untreated animals or animals that received the less active compounds. Animals receiving P7C3A20 also performed better in analysis of their walking gait, which typically worsens in these animals as the disease progresses.
In PD, dopamine-producing neurons necessary for normal movement are gradually destroyed. In patients, loss of these brain cells leads to tremors, stiffness, and difficulty walking. The study again showed that P7C3 protects these neurons from cell death and the more active analogue, P7C3A20, provided even greater protection.
The two compounds also potently blocked cell death of dopaminergic neurons in a C. elegans worm model of PD. Moreover, reduced cell death in this model was associated with improved movement in the worms.
Healthy C. elegans worms have a very characteristic swimming motion. This movement is disrupted in the PD worm. Hector De Jesus-Cortes, a graduate student of neuroscience at UT Southwestern Medical Center and lead author of the Parkinson's study, videotaped and analyzed the PD worms' mobility with and without treatment. Normal swimming was almost completely preserved with P7C3A20, and was also fairly well preserved with P7C3.
Tweaking the molecule
The research team compared the activity of several new P7C3-related compounds that they synthesized, in both the hippocampal neurogenesis screen and the mouse model of PD.
"Every variation of our P7C3 molecule that works in the neurogenesis assay also works in the PD model," Pieper says. "As we continue to refine the molecule, our hope is that the results from the neurogenesis assay will accurately predict the neuroprotective potency of the compound, and thus aid in more rapidly optimizing a new neuroprotective agent."
The team plans to continue tweaking the structure of the P7C3 molecule to improve its neuroprotective ability while eliminating potential side effects.
"Our hope is that this work will form the basis for designing a neuroprotective drug that could eventually help patients," Pieper says.
###
Pieper and De Jesus-Cortes conducted the study with colleagues at UT Southwestern Medical Center, including Steven McKnight, Ph.D., chairman of biochemistry, and Joseph Ready, Ph.D., professor of biochemistry. The work was funded in part by grants from the National Institute for Mental Health.
Potential new class of drugs blocks nerve cell death
Potential new class of drugs protects nerve cells in models of Parkinson's disease and amyotrophic lateral sclerosis
2012-10-02
ELSE PRESS RELEASES FROM THIS DATE:
Homolog of mammalian neocortex found in bird brain
2012-10-02
A seemingly unique part of the human and mammalian brain is the neocortex, a layered structure on the outer surface of the organ where most higher-order processing is thought to occur. But new research at the University of Chicago has found the cells similar to those of the mammalian neocortex in the brains of birds, sitting in a vastly different anatomical structure.
The work, published in Proceedings of the National Academy of Sciences, confirms a 50-year-old hypothesis about the identity of a mysterious structure in the bird brain that has provoked decades of scientific ...
Penn researchers connect baboon personalities to social success and health benefits
2012-10-02
PHILADELPHIA — Whether human or baboon, it helps to have friends. For both species, studies have shown that robust social networks lead to better health and longer lives. Now, a team of University of Pennsylvania researchers has helped show that baboon personality plays a role in these outcomes, and, like people, some baboons' personalities are better suited to making and keeping friends than others.
The research was conducted by psychology professor Robert Seyfarth and biology professor Dorothy Cheney, both of Penn's School of Arts and Sciences. They collaborated with ...
A simple blood test could be used to detect breast cancer
2012-10-02
A SIMPLE blood test could one day be a more accurate way to test for the early signs of breast cancer than using mammograms to spot a lump say researchers today (Tuesday), as Breast Cancer Awareness Month gets underway.
They also hope the blood test could improve treatment by detecting whether breast cancer patients are likely to relapse and what drugs their particular type of tumour will respond to.
This pioneering new clinical study – funded by Cancer Research UK in collaboration with the University of Leicester and Imperial College London – is about to start in the ...
Breakthrough in understanding lung cancer vulnerabilities points the way to new targeted therapy
2012-10-02
More effective treatments for one of the deadliest forms of cancer are one step closer thanks to groundbreaking research from an international collaborative study.
Scientists from the Universities of Sheffield and Cologne have identified the dependencies of multiple Small Cell Lung Cancer (SCLC) types – paving the way for clinical trials of new targeted treatments which could revolutionise the current approach.
Around 40,000 people are diagnosed annually with lung cancer in the UK, and SCLC accounts for nearly one in five of all these cases.
Unfortunately, the prognosis ...
Severely obese are fastest growing group of overweight Americans, study finds
2012-10-02
The proportion of Americans who are severely obese -- those people 100 pounds or more overweight -- continues to increase rapidly and much faster than those with moderate obesity, but the rate of growth has slowed, according to a new RAND Corporation study.
The RAND study found that from 2000 to 2010, the proportion of Americans who were severely obese rose from 3.9 percent of the population to 6.6 percent -- an increase of about 70 percent.
The findings mean that more than 15 million adult Americans are morbidly obese with a body mass index of 40 or more. The good ...
Meeting pigs' phosphorous requirements with fermented soybean meal
2012-10-02
Fermented soybean meal (FSBM), considered a promising substitute for fish meal in weanling pig diets because of its protein content, lower cost, and lack of anti-nutritional factors, may have an additional advantage. University of Illinois researchers recently found that pigs digest the phosphorous in FSBM better than the phosphorus in conventional soybean meal.
"Most of the P in soybean meal is bound to phytate, so it's not available to pigs," explained animal sciences professor Hans Stein.
Previous research by Stein's group found that pigs digest the phosphorous in ...
Marine animals could hold the key to looking young
2012-10-02
Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies, and could hold the key to maintaining a youthful appearance, according to scientists at Queen Mary, University of London.
The researchers investigated the genes of marine creatures such as sea urchins and sea cucumbers, known as echinoderms. They found the genes for "messenger molecules" known as peptides, which are released by cells and tell other cells in their bodies what to do.
The study was published online in the journals PLOS One and General and Comparative Endocrinology. ...
Climate change cripples forests
2012-10-02
LOS ALAMOS, N.M., Oct. 1, 2012— Combine the tree-ring growth record with historic information, climate records and computer-model projections of future climate trends, and you get a grim picture for the future of trees in the southwestern United States. That's the word from a team of scientists from Los Alamos National Laboratory, the U.S. Geological Survey, University of Arizona, and several other partner organizations.
Described in a paper published in Nature Climate Change this week, "Temperature as a potent driver of regional forest drought stress and tree mortality," ...
No relief for relief workers: Humanitarian aid work raises risk of depression and anxiety
2012-10-02
Humanitarian workers are at significant risk for mental health problems, both in the field and after returning home. The good news is that there are steps that they and their employers can take to mitigate this risk.
These findings, from a new study by scientists at the U.S. Centers for Disease Control and Prevention (CDC) and collaborators, including Columbia University's Mailman School of Public Health, are published online in the journal PLOS ONE.
Researchers surveyed 212 international humanitarian workers at 19 NGOs. Prior to deployment, 3.8% reported symptoms of ...
Novel gene associated with Usher syndrome identified
2012-10-02
LEXINGTON, Ky. (Oct. 1, 2012) — Usher syndrome is a hereditary disease in which affected individuals lose both hearing and vision. The impact of Usher syndrome can be devastating. In the United States, approximately six in every 100,000 babies born have Usher syndrome.
Several genes associated with different types of Usher syndrome have been identified. Most of these genes encode common structural and motor proteins that build sensory cells in the eye and inner ear.
In a paper to be published in the November 2012 issue of Nature Genetics, a team of researchers from ...
LAST 30 PRESS RELEASES:
Air pollution impacts an aging society
UC Davis researchers achieve total synthesis of ibogaine
Building better biomaterials for cancer treatments
Brain stimulation did not improve impaired motor skills after stroke
Some species of baleen whales avoid attracting killer whales by singing too low to be heard
Wasteful tests before surgery: Study shows how to reduce them safely
UCalgary researchers confirm best approach for stroke in medium-sized blood vessels
Nationwide, 34 local schools win NFL PLAY 60 grants to help students move more
New software developed at Wayne State University will help study chemical and biological systems
uOttawa study unveils new insights into how neural stem cells are activated in the adult human brain
Cystic fibrosis damages the immune system early on
Novel ‘living’ biomaterial aims to advance regenerative medicine
Warding off superbugs with a pinch of turmeric
Ophthalmic complications in patients on antidiabetic GLP-1 medications are concerning neuro-ophthalmologists
Physicians committee research policy director speaks today at hearing on taxpayer funded animal cruelty
New technology lights way for accelerating coral reef restoration
Electroencephalography may help guide treatments for language disorders
Multinational research project shows how life on Earth can be measured from space
Essential genome of malaria parasite Plasmodium knowlesi mapped
Ice streams move due to tiny ice quakes
Whale song has remarkable similarities to human speech in terms of efficiency
Uncovered: How mice override instinctive fear responses
A pathway that contributes to insulin resistance can be targeted, mouse study shows
Special Issue: The cryosphere
Scientists discover brain mechanism that helps overcome fear
Mantis shrimp clubs filter sound to mitigate damage
Large differences in water-seeking ability found in U.S. corn varieties
Whale song has structure similar to human language
Cracking the Burmese python code: New data zeroes in on game-changing strategies
Risk it or kick it? Study analyzes NFL coaches’ risk tolerance on fourth down
[Press-News.org] Potential new class of drugs blocks nerve cell deathPotential new class of drugs protects nerve cells in models of Parkinson's disease and amyotrophic lateral sclerosis